Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
申请人:Cephalon Australia Pty Ltd
公开号:EP2392598A1
公开(公告)日:2011-12-07
The present invention provides an isolated specific binding member capable of binding a sialyltetraosyl carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.
MONOCLONAL ANTIBODY SC104 AND DERIVATIVE THEREOF SPECIFICALLY BINDING TO A SIALYLTETRAOSYL CARBOHYDRATE AS A POTENTIAL ANTI-TUMOR THERAPEUTIC AGENT
申请人:Scancell Limited
公开号:EP1745077A2
公开(公告)日:2007-01-24
Monoclonal Antibody Sc104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
申请人:Durrant Linda Gillian
公开号:US20080118509A1
公开(公告)日:2008-05-22
The present invention provides an isolated specific binding member capable of binding a sialyltetraosly carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.
Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
申请人:Durrant Linda Gillian
公开号:US20110212113A1
公开(公告)日:2011-09-01
The present invention provides an isolated specific binding member capable of binding a sialyltetraosyl carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.